Dmitri O Dormeshkin

6PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
Correction: Lutskovich et al. Comparative Preclinical Analysis of Anti-B7-H3 CAR-T Cells Targeting Neuroblastoma. Biomedicines 2025, 13, 2130.

|Sep 27, 2025
Comparative Preclinical Analysis of Anti-B7-H3 CAR-T Cells Targeting Neuroblastoma.

Dzmitry V Lutskovich, Alexander N Meleshko, Valeria M Stepanova

|Nov 29, 2023
CAR-T Cell Therapy for Classical Hodgkin Lymphoma.

Mikalai Katsin, Dmitri Dormeshkin, Alexander Meleshko

|Jun 28, 2023
Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein.

Dmitri Dormeshkin, Mikalai Katsin, Maria Stegantseva

|Jul 27, 2022
Safety and Immunogenicity of Combined DNA-Polyethylenimine and Oral Bacterial Idiotypic Vaccine for Patients with B-Cell Non-Hodgkin Lymphoma: A Pilot Study.

Alexander Meleshko, Nadzeya Piatrouskaya, Katsiaryna Vashkevich

|Jun 20, 2022
Combining of synthetic VHH and immune scFv libraries for pregnancy-associated glycoproteins ELISA development.

Dmitri Dormeshkin, Michail Shapira, Alena Karputs

Pageof 1

Frequent Collaborators

4 joint publications

Alexander N Meleshko

1 joint publications

Anton Kavaleuski

1 joint publications

Alexandr Migas

1 joint publications

Valeria M Stepanova